跳至主要内容
临床试验/NCT05005650
NCT05005650已完成不适用

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy on Stage IVB Ovarian Cancer With Supradiaphragmatic Lymph Node Metastasis

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
121
试验地点
1
主要终点
Progression-free survival

研究概览

简要总结

To evaluate the survival impact of extensive lymphadenectomy as part of debulking surgery in stage IVB ovarian cancer with supradiaphragmatic lymph node metastasis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Histologically diagnosed ovarian, fallopian tubal, primary peritoneal cancer
  • Patients suspected of metastatic lymph nodes in the cardiophrenic, internal mammary, and/or supraclavicular lymph node by CT (size larger than 5mm)
  • Patients clinically diagnosed FIGO stage IVB ovarian, fallopian tubal, primary peritoneal cancer
  • Patients underwent debulking surgery (primary debulking surgery or interval debulking surgery) at Seoul National University Hospital from January 2010 to January 2020
  • Patients age 18-90

排除标准

  • Borderline or benign ovarian disease
  • Patient didn't undergo debulking surgery
  • Non-epithelial ovarian cancer

结局指标

主要结局

Progression-free survival

时间窗: From date of treatment until the date of first documented progression or date of death (by any cause, in the absence of disease progression) whichever came first, assessed up to 120 months

the time interval from the treatment start date to disease recurrence or progression date

次要结局

  • Overall survival(From the date of treatment start date until death due to any cause, assessed up to 120 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hee Seung Kim

Associate Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验